Vasoplegia clinical trials at UCSF

1 research study open to eligible people

Vasoplegia is when blood pressure drops too low. UCSF is doing a study about a drug called Angiotensin II and its safety when used as a second-line option during liver transplantation. The study will test how well Angiotensin II works as a vasopressor, which raises blood pressure.

Showing trials for

  • Angiotensin II in Liver Transplantation

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

    San Francisco, California

Our lead scientists for Vasoplegia research studies include .

Last updated: